title: Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
authors.forename: S
authors.initials: S
authors.lastname: Santolaria
authors.forename: R
authors.initials: R
authors.lastname: Guirao
authors.forename: J
authors.initials: J
authors.lastname: Ducóns
authors.forename: J G
authors.initials: JG
authors.lastname: Cabezudo
authors.forename: M
authors.initials: M
authors.lastname: Montoro
authors.forename: F
authors.initials: F
authors.lastname: Gomollon
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005756:Gastritis / Q000188:drug therapy; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy; D011899:Ranitidine / Q000031:analogs & derivatives / Q000627:therapeutic use*
chemical_list: D000897:Anti-Ulcer Agents; C073340:ranitidine bismuth citrate; D011899:Ranitidine; D017291:Clarithromycin; D001729:Bismuth